Loading...
Combination of Olanzapine and Samidorphan Has No Clinically Significant Effect on the Pharmacokinetics of Lithium or Valproate
BACKGROUND AND OBJECTIVE: Olanzapine is an atypical antipsychotic indicated for the treatment of schizophrenia and, either as monotherapy or as an adjunct to lithium or valproate, for bipolar I disorder. Multiple daily doses of olanzapine do not affect the pharmacokinetics of lithium or valproate; t...
Saved in:
| Published in: | Clin Drug Investig |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer International Publishing
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6962313/ https://ncbi.nlm.nih.gov/pubmed/31584140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-019-00860-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|